Change in the serologic markers of hepatitis B after allogenic hematopoietic stem-cell transplantation / 대한간학회지
The Korean Journal of Hepatology
; : 131-139, 2009.
Article
de Ko
| WPRIM
| ID: wpr-111399
Bibliothèque responsable:
WPRO
ABSTRACT
BACKGROUND/AIMS: This study examined the effects of hepatitis B virus (HBV) infection state and immunologic capability in both the recipients and donors of allogenic hematopoietic stem-cell transplantation (allo-HSCT) on changes in HBV serologic markers in recipients. METHODS: A total of 537 patients underwent allo-HSCT for the treatment of leukemia, malignant lymphoma, and solid tumor. HBV serologic markers were examined in both recipients and donors prior to and following the transplantation. The mean follow-up period was 36.6 months (range 3-80 months). RESULTS: Of the 537 patients who underwent allo-HSCT, 45 recipients were positive for HBsAg prior to transplantation. Of these 45 patients, 21 were transplanted from anti-HBs-positive donors and the remaining 24 were transplanted from anti-HBs-negative donors. In the former cases, seroconversion was noted in 4 of the 21 patients (19%). In the latter cases, however, no seroconversion was noted following the transplantation. Thirty patients who were negative for both HBsAg and anti-HBs were transplanted from anti-HBs-positive donors, and 15 out of 30 patients (50%) acquired anti-HBs. Four hundred and seven patients who were positive for anti-HBs were transplanted from anti-HBs-positive or HbsAg-negative donors; 8 of these proved HBsAg-positive following the transplantation. There were no changes in HBV serological markers following transplantation in 41 patients who were transplanted from HbsAg-positive donors. CONCLUSIONS: Due to the adoptive immunity that was transferred from anti-HBs-positive donors, a seroconversion of HBsAg could occur in some HBsAg-positive recipients. HBsAg-positive donors had a lesser effect on the HBV serologic markers of recipients. However, a reactivation of HBV can occur following hematopoietic stem-cell transplantation in the cases of recipients or donors with a history of HBV, infection by an accompanying immune suppression. Therefore, prevention should be instigated.
Mots clés
Texte intégral:
1
Indice:
WPRIM
Sujet Principal:
Donneurs de tissus
/
Transplantation homologue
/
Activation virale
/
Marqueurs biologiques
/
Études rétrospectives
/
Transplantation de cellules souches hématopoïétiques
/
Hépatite B
/
Anticorps de l'hépatite B
/
Antigènes de surface du virus de l'hépatite B
Type d'étude:
Observational_studies
Limites du sujet:
Adolescent
/
Adult
/
Aged
/
Female
/
Humans
/
Male
langue:
Ko
Texte intégral:
The Korean Journal of Hepatology
Année:
2009
Type:
Article